KLA Corporation (KLAC) Tops Q1 EPS by 21c; offers guidance

KLA Corporation (NASDAQ: KLAC) reported Q1 EPS of $8.81, $0.21 better than the analyst estimate of $8.60. Revenue for the quarter came in at $3.21 billion versus the consensus estimate of $3.17 billion.

GUIDANCE:

KLA Corporation sees Q2 2026 EPS of $8.70 +/- $0.78, versus the consensus of $8.51. KLA Corporation sees Q2 2026 revenue of $3.225 billion +/- $150 million, versus the consensus of $3.162 billion.

For earnings history and earnings-related data on KLA Corporation (KLAC) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance